Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosis-Reference-Cited by-同舟云学术

Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosis

Published:2022-07 Issue:7 Volume:4 Page:e462-e464
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

Wallwork Rachel,Connolly Caoilfhionn M,Shneyderman Matthew,McMahan Zsuzsanna,Mecoli Christopher A,Wigley Fredrick,Hummers Laura K,Shah Ami A,Paik Julie J

Funder

Scleroderma Research Foundation

National Institutes of Health

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference9 articles.

1. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients;Boyarsky;JAMA,2021

2. Effect of Immunosuppression on the immunogenicity of mRNA vaccines to SARS-CoV-2: a prospective cohort study;Deepak;Ann Intern Med,2021

3. Treatment algorithms for systemic sclerosis according to experts;Fernández-Codina;Arthritis Rheumatol,2018

4. Increased odds of death for patients with interstitial lung disease and COVID-19: a case-control study;Esposito;Am J Respir Crit Care Med,2020

5. Antibody kinetics in patients with rheumatic diseases after SARS-CoV-2 mRNA vaccination;Frey;Lancet Rheumatol,2021

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 prophylaxis, diagnostics, and treatment in patients with rheumatic diseases. The Polish experts panel opinion;Rheumatology;2024-03-18

2. Risk factors and outcomes for repeat COVID-19 infection among patients with systemic autoimmune rheumatic diseases: A case-control study;Seminars in Arthritis and Rheumatism;2023-12

3. Effect of Immunosuppressive or Immunomodulatory Agents on Severe COVID‐19 Outcomes: A Population‐Based Cohort Study;ACR Open Rheumatology;2023-10-11

4. Impact of methotrexate on humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis;Clinical and Experimental Medicine;2023-08-16

5. Preventative Care in Scleroderma;Rheumatic Disease Clinics of North America;2023-05